Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Revenue: 2019-2024

Historic Revenue for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $39.0 million.

  • Eton Pharmaceuticals' Revenue rose 117.54% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.8 million, marking a year-over-year decrease of 4.10%. This contributed to the annual value of $39.0 million for FY2024, which is 23.29% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Revenue stood at $39.0 million for FY2024, which was up 23.29% from $31.6 million recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Revenue high stood at $39.0 million for FY2024, and its period low was $39,000 during FY2020.
  • For the 3-year period, Eton Pharmaceuticals' Revenue averaged around $30.6 million, with its median value being $31.6 million (2023).
  • In the last 5 years, Eton Pharmaceuticals' Revenue tumbled by 95.93% in 2020 and then soared by 55,879.49% in 2021.
  • Eton Pharmaceuticals' Revenue (Yearly) stood at $39,000 in 2020, then surged by 55,879.49% to $21.8 million in 2021, then fell by 2.66% to $21.3 million in 2022, then skyrocketed by 48.90% to $31.6 million in 2023, then climbed by 23.29% to $39.0 million in 2024.